COVID-19 - State of emergency renewed for the urban agglomeration of Montréal
MONTRÉAL, Aug. 13, 2021 /CNW Telbec/ - In accordance with the Civil Protection Act, Montréal's executive committee has renewed the state of emergency for the urban agglomeration of Montréal on August 13, for a period of five days.
The local state of emergency, which was declared on March 27, 2020, grants exceptional powers to the urban agglomeration, enabling it to respond to the current pandemic across its territory. In particular, it gives the urban agglomeration the power to mobilize the necessary resources and workforce to fight COVID-19.
The urban agglomeration of Montréal continues to collaborate closely with its team of experts from its emergency response coordination centre, the regional public health department and the healthcare and social services network, in order to fight the spread of COVID-19.
The Phase IIa COURSE trial was a proof-of-concept study in people with moderate to very severe chronic obstructive pulmonary disease (COPD) with a broad range of blood eosinophil counts (BEC) and irrespective of emphysema, chronic bronchitis or...
Amgen and AstraZeneca today announced the results of the Phase 2a COURSE trial evaluating Tezspire® (tezepelumab-ekko) in people with moderate to very severe chronic obstructive pulmonary disease (COPD) with a broad range of baseline blood...
Emmy-winning actor and St. Louis native Jon Hamm took the stage Saturday, May 18, to offer words of wisdom to the newest graduates of Saint Louis University (SLU) during the University's spring commencement in St. Louis. ...
Nearly 900 undergraduates of the Class of 2024 celebrated their send-off from Bentley University in a very different way than their 2020 arrival amid the COVID-19 pandemic. The 105th undergraduate commencement ceremony was marked by maskless smiles,...
Gilead Sciences, Inc. , following the recent acquisition of CymaBay Therapeutics, Inc., today announced interim results from the ongoing ASSURE study demonstrating treatment with seladelpar, an investigational PPAR delta agonist, led to improvements...
Mirum Pharmaceuticals, Inc. today announced data presented during the 56th European Society for Paediatric, Gastroenterology, Hepatology, and Nutrition (ESPGHAN) Annual Meeting which took place this week in Milan, Italy. Data from LIVMARLI®...